Single dose use of CD20-specific binding molecules

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080213273A1
SERIAL NO

11493241

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides materials and methods for treatment of diseases involving aberrant B-cell activity using a single dose of CD20-specific binding molecule.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC2401 FOURTH AVENUE SUITE 1050 SEATTLE WA 98121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burge, Daniel J Sammamish, WA 1 80

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation